Waldemar Priebe
Impact in
- Oncology top 0.5%
- Cytokine Signaling Pathways and Interactions
- Drug Transport and Resistance Mechanisms
- Cancer Cells and Metastasis
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 122
- Drug Transport and Resistance Mechanisms 29
- Cytokine Signaling Pathways and Interactions 28
- Cancer Treatment and Pharmacology 21
-
- Cancer, Hypoxia, and Metabolism 27
- Co-authors
- Izabela FoktAmy B. HeimbergerRomán Pérez-SolerJonathan B. ChairesJun WeiLing-Yuan KongRaymond SawayaDerek Horton
- Journals
- Cancer Research (17 papers)Carbohydrate Research (17 papers)Blood (17 papers)Cancer Chemotherapy and Pharmacology (9 papers)Biochemical Pharmacology (9 papers)
- Partner nations
- United StatesPolandFrance
In The Last Decade
Waldemar Priebe
254 papers receiving 9.4k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Oncology 3.6k
- Cancer Research 1.7k
- Genetics 1.2k
- Toxicology 253
- Molecular Biology 4.9k
Countries citing papers authored by Waldemar Priebe
This map shows the geographic impact of Waldemar Priebe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Waldemar Priebe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Waldemar Priebe more than expected).
Fields of papers citing papers by Waldemar Priebe
This network shows the impact of papers produced by Waldemar Priebe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Waldemar Priebe. The network helps show where Waldemar Priebe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Waldemar Priebe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 58 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 6 | |
| 8 | 2021 | 6 | |
| 9 | 2021 | 74 | |
| 10 | 2020 | 41 | |
| 11 | 2019 | 14 | |
| 12 | 2010 | 46 | |
| 13 | 2-Deoxy-2-fluoro-D-mannose induces type II cell death in gliomas. | 2008 | 2 |
| 14 | 2007 | 246 | |
| 15 | Phase I clinical pharmacokinetics of RTA 744 (berubicin(B)), a blood-brain barrier penetrating anthracycline active against high grade glioma, and evaluation of its 13-hydroxy metabolite, berubicinol (B-ol) | 2007 | 2 |
| 16 | WP1066, a potent inhibitor of Jak2/STAT3 pathway inhibits pancreatic tumor growth both in vitro and in vivo | 2007 | 7 |
| 17 | Degradation of c-Myc by WP1130 Through Activation of a Novel Proteasomal-Dependent Pathway | 2006 | 1 |
| 18 | 2001 | 8 | |
| 19 | NOVEL SYNTHESIS OF ANOMERIC PEROXIDES AND HYDROPEROXIDES | 1999 | 0 |
| 20 | A facile transformation of benzylated methyl glycosides to thioglycosides | 1996 | 0 |
About Waldemar Priebe
Waldemar Priebe is a scholar working on Oncology, Cancer Research, Genetics, Toxicology and Molecular Biology, having authored 261 papers that have together received 9.5k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (47 papers), Carbohydrate Chemistry and Synthesis (31 papers), Drug Transport and Resistance Mechanisms (29 papers), Cytokine Signaling Pathways and Interactions (28 papers), DNA and Nucleic Acid Chemistry (27 papers), Cancer, Hypoxia, and Metabolism (27 papers), Glycosylation and Glycoproteins Research (21 papers) and Cancer Treatment and Pharmacology (21 papers). The work is most often cited by research in Oncology (3.6k citations), Cancer Research (1.7k citations), Genetics (1.2k citations), Toxicology (253 citations) and Molecular Biology (4.9k citations). Waldemar Priebe has collaborated with scholars based in United States, Poland and France. Frequent co-authors include Izabela Fokt, Amy B. Heimberger, Román Pérez-Soler, Jonathan B. Chaires, Jun Wei, Ling-Yuan Kong, Raymond Sawaya, Derek Horton, Niramol Savaraj and Théodore J. Lampidis. Their work appears in journals such as Cancer Research, Carbohydrate Research, Blood, Cancer Chemotherapy and Pharmacology and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.